date_range Event date: 21/07/17
access_time 12:00 - 15:30
location_on University of Leeds, Seminar Room 9.58b
Special Seminar: What makes research interesting to investors?
Matthew Durdy – Chief Business Officer of the Cell and Gene Therapy Catupult.
Agenda:
12pm -1pm Workshop
1pm-1.30pm Networking lunch
If you would like to meet with Matthew following the seminar, contact b.morrissey@leeds.ac.uk
Matthew Durdy, Chief Business Officer – Matthew joined the Cell and Gene Therapy Catapult in 2012, from the novel therapeutics company Aqix, where he was Chief Executive.
He has broad experience in the biotechnology industry leading SMEs, raising finance and commercialising diagnostics, medical devices, and therapeutics for regulated use in the EU. He was also an expert advisor to the World Health Organisation on medical innovation strategy. Matthew was also a Director at the venture capital firm CDC, where he was responsible for due diligence and new investment in their $3.5bn international portfolio. He completed his training in corporate finance and international investment banking at Bank of America Hoare Govett and Prudential Bache in New York and London. He has a BA in pure and applied biology from Christ Church, University of Oxford, and an MBA from the University of Chicago Graduate School of Business, where he also assists in teaching new venture strategy on their MBA programme.
Book now 
